Objectives To evaluate the efficacy and safety of certolizumab pegol (CZP) after 24 weeks in
RAPID-axSpA (NCT01087762), an ongoing Phase 3 trial in patients with axial …

Objective To report the long-term safety data of certolizumab pegol (CZP) in rheumatoid
arthritis (RA) accumulated as of 30 November 2011. Design Data from 10 completed …

Background: No study has compared allergic sensitization patterns in infants with atopic
eczema from different countries. The aim of this study was to investigate the patterns of …

A Course in Topological Combinatorics is the first undergraduate textbook on the field of
topological combinatorics, a subject that has become an active and innovative research …

Objective. To evaluate the humoral immune response to pneumococcal and influenza
vaccination in adults with rheumatoid arthritis (RA) receiving certolizumab pegol (CZP) …

The recently introduced A-homotopy groups for graphs are investigated. The main concern
of the present article is the construction of an infinite cell complex, the homotopy groups of …

The ETAC (Early Treatment of the Atopic Child) study, a multi‐national double‐blind placebo‐
controlled randomized trial, has been in progress since 1994. Fifty‐six centers in Europe …

Three patients with symptomatic metastatic medullary thyroid carcinoma (MTC), one with
sporadic form and two with MEN IIa, were treated with the long‐acting somatostatin …

Objective Previous reports of RAPID-PsA (NCT01087788) demonstrated efficacy and safety
of certolizumab pegol (CZP) over 24 weeks in patients with psoriatic arthritis (PsA), including …

Objective To review long-term certolizumab pegol (CZP) safety across all approved
indications: rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), psoriatic arthritis …